fbpx Treat the patient, not a checklist - Dr Munir Khani from American University of Beirut Medical Center, Lebanon | Progress In Mind

Treat the patient, not a checklist - Dr Munir Khani from American University of Beirut Medical Center, Lebanon

That is the approach advocated by Dr Munir Khani, Associate Professor of Psychiatry at the American University of Beirut Medical Center, Lebanon, as expressed during an interview at ECNP

How do you diagnose major depressive disorder?

This is a problem area. Psychiatric disorders in general and depression in particular have been reduced to checklists. Doctors now are taught to treat depression, and not the patient with depression.

I focus on rapport and try to gather as much information as possible, from the patient and from the family, before reaching a realistic diagnosis. I look for major vegetative symptoms, for issues relating to functioning in the family, occupation and wider society, and for a sense of whether the person is finding enjoyment in leisure activities.

I am also very concerned to see if there is any suicidal ideation. That is a possibility in every patient, and we must assess its level.

What challenges do you face in treatment?

Delaying treatment promotes chronicity

A problem we have in our hospital practice is that we generally have no real contact with the patient’s general practitioner. That relationship needs to be consolidated. The family physician may already have made a diagnosis of depression – in which case we need to confirm it -- and perhaps started treatment. By the time patients get to us, some have already tried several antidepressants and may have almost given up on treatment.

Comorbidities are also a major problem. These can be psychiatric, or medical, or both. If you don’t take care of issues such as substance abuse, you’ll get nowhere in treating the depression.

Another issue is the cognitive decline of patients. We have not had a sensitive scale to assess function. The ideal is full neuropsychological testing, but that is an expense patients are reluctant to bear. The Hamilton and Beck scales, for example, don’t pay much attention to cognition. The THINC-it® tool should be given a chance and may prove to be what we really need.

Do you combine pharmacological treatment with psychotherapy?

Yes. Treatment should be holistic and reflect every aspect of life, not just the depression. People with depression are human beings, just like us.

We refer most of our patients to a psychologist for individual or family psychotherapy, and that makes a huge difference. There have been great advances in this field. CBT is very à la mode.

We also use ECT in cases of resistant depression, and in MDD with psychotic symptoms or suicidal ideation.

A key issue is the need for early treatment. Delay promotes chronicity. Once depression is prolonged, the anatomical changes in the brain may not be reversible, whatever you do.

How do you define remission?

Not just as relief of symptoms. A lot of patients who are essentially asymptomatic – and this goes for bipolar too – are still way down on functionality.  So I look at personal, family and social circumstances; and for a positive emotional state, and restored interest in work, for example. I hate reducing psychiatry to a checklist. But it is what residents are being taught!

You are leaving Progress in Mind
Le informazioni contenute nel nuovo sito prescelto possono non essere conformi al D.Ivo 219/06 che regola la pubblicità dei medicinali per uso umano e le opinioni espresse non riflettono necessariamente le posizioni dell’azienda, non sono da essa avvallate.
Accesso riservato a Operatori Sanitari
Per accedere si prega di registrarsi o, in caso sia già stato fatto, di autenticarsi
L’accesso a Progress in Mind Italia è consentito unicamente agli Operatori Sanitari (medici e farmacisti). I contenuti di questo sito sono prodotti da un team di Operatori Sanitari il cui obiettivo è presentare le ultime novità in ambito psichiatrico e neurologico, attraverso interviste, registrazioni audio/video di seminari con opinion leader, report e sintesi di congressi sia internazionali che nazionali. Per poter accedere al sito è quindi necessario registrarsi e fornire alcuni dati così da poter verificare che l‘utente sia un Operatore Sanitario.
Per accedere alla pagina si prega di registrarsi o, in caso sia già stato fatto, di autenticarsi. La pagina per la quale sta richiedendo l'accesso ospita materiale formativo comunque attinente all'impiego di medicinali prodotti o commercializzati da Lundbeck. Con riferimento al Decreto Legislativo n.219 del 24 aprile 2006 e s.m.i., art. 119, art. 121 comma 1 e art. 124 commi 4 e 8, Lundbeck limita l'accesso ai contenuti presenti nella pagina PIM Academy a medici specialisti e farmacisti ospedalieri.
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country